Stockreport

Pansend Life Sciences’ Portfolio Company MediBeacon Announces $30 Million Investment from Huadong Medicine and Exclusive Commercialization Partnership in Greater China

HC2 Holdings, Inc.  (HCHC) 
NASDAQ:AMEX Investor Relations: ir.hc2.com
PDF - MediBeacon and Huadong Medicine will collaboratively work to reach regulatory approval on MediBeacon’s entire portfolio of assets in Greater China - NEW YORK, July [Read more]